S. 2336: A bill to ensure references to opioid overdose reversal agents in certain grant programs of the Department of Health and Human Services are not limited to naloxone.
Sponsors
2 bill sponsors
Actions
2 actions
| Date | Action |
|---|---|
| Jul. 17, 2025 | Introduced in Senate |
| Jul. 17, 2025 | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
Corporate Lobbying
0 companies lobbying
None found.
* Note that there can be significant delays in lobbying disclosures, and our data may be incomplete.
Potentially Relevant Congressional Stock Trades
No relevant congressional stock trades found.